Albemarle Corporation (ALB) Stock Price: $141.05-6.79 (-4.59%)
At close: Jun 25, 2026, 4:00 PM ET
The closing share price for Albemarle Corporation (ALB) stock was $141.05 for Thursday, June 25, 2026, down 4.59% on the day.
Longer view (total return, dividends reinvested): past 12 months +136.9% · 3-year avg -12.4%/yr · 5-year avg -2.1%/yr
ALB Price Chart
ALB Key Metrics
See All MetricsLAST CLOSE PRICE
$141.05
52-WEEK RANGE
$60.64 - $221.00
BETA
1.31
% FROM 52W HIGH
-36.18%
MARKET CAP
$16.63B
DIVIDEND YIELD
1.15%
PE RATIO
trailing TTM
N/A
PE RATIO (FWD)
next-FY estimate
11.26
P/B RATIO
1.70
DEBT / EQUITY
0.35
REVENUE TTM
$5.49B
NET INCOME TTM
-$232.88M
NET PROFIT MARGIN TTM
-4.24%
TTM TOTAL RETURN
+136.87%
3Y TOTAL RETURN
-12.44%
5Y TOTAL RETURN
-2.13%
ALB Revenue by Segment
How ALB’s revenue breaks down across its reported segments in the latest reported fiscal year.
By product / business (FY 2025)
- Energy Storage$2.71B52.7%
- Specialties$1.37B26.6%
- Ketjen$1.07B20.7%
ALB Earnings Preview
Next Earnings Date
Jul 29, 2026
33 days away
EPS Estimate
3.08
Revenue Est.
$1.58B
Last Quarter Results
EPS
$2.95
vs Estimate
$1.31
Revenue
$1.43B
vs Estimate
$1.34B
ALB Analyst Ratings
Consensus Rating
Based on 22 analysts
Average Price Target
$214.65
+52.2% upside
Low
$83.28
Current
$141.05
High
$264.00
ALB Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $2.36 | $2.92 | $3.81 | 4 |
| Q2 2027 | $2.93 | $3.63 | $4.73 | 4 |
| Q3 2027 | $2.72 | $3.36 | $4.39 | 4 |
| Q4 2027 | $2.42 | $2.99 | $3.91 | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $7.67 | $12.52 | $18.00 | 12 |
| FY 2028 | $7.70 | $12.42 | $21.51 | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $1.48B | $1.73B | $2.14B | 5 |
| Q2 2027 | $1.60B | $1.88B | $2.32B | 5 |
| Q3 2027 | $1.51B | $1.77B | $2.18B | 5 |
| Q4 2027 | $1.45B | $1.69B | $2.09B | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $6.14B | $6.70B | $8.00B | 14 |
| FY 2028 | $6.82B | $6.90B | $6.98B | 12 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
Related Stocks
Basic MaterialsALB Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ALB | $16.63B | $141.05 | -4.59% | +136.87% | -2.13% | +7.40% | — |
| 2CF | $16.21B | $105.51 | +2.35% | +17.89% | +17.95% | +18.47% | vs ALB |
| 3CX | $17.91B | $12.02 | -1.15% | +84.87% | +7.91% | +8.68% | vs ALB |
| 4DD | $18.61B | $137.80 | -0.01% | +64.51% | +9.56% | +6.16% | vs ALB |
| 5IFF | $19.17B | $75.08 | -0.99% | +3.58% | -10.44% | -2.39% | vs ALB |
| 6AA | $14.01B | $53.08 | +1.49% | +90.25% | +9.25% | +10.27% | vs ALB |
ALB Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Albemarle Corporation
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Jerry Kent Jr.